Premaitha Health PLC | |
Stock Exchange | London Stock Exchange |
EPS |
- |
Market Cap |
GBP44.68 M |
Shares Outstanding |
386.84 M |
Public Float |
244.5 M |
Address |
Rutherford House Manchester Greater Manchester M15 6SZ United Kingdom |
Employees | - |
Website | http://premaitha.com/ |
Updated | 09/14/2018 |
Premaitha Health Plc engages in the manufacture, development and sale of molecular diagnostic products. Its product IONA test, which is marked as non-invasive in vitro diagnostic product for prenatal screening. The company was founded in 2013 and is headquartered in Manchester, the United Kingdom. |